Navigation Links
ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert;
Date:5/4/2009

Patients Experience Significant Improvement in Ocular Surface Disease and Quality of Life

LAWRENCEVILLE, N.J., May 4 /PRNewswire/ -- Aton Pharma, Inc. announced today that results from a large (n = 520) multi-center patient registry study of its Lacrisert(R) ophthalmic insert will be presented this week during the 2009 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), May 3-7, Ft. Lauderdale, FL, and later in the month at the 145th Annual Meeting of the American Ophthalmological Society (AOS), May 14 -17, Half Moon Bay, CA. Lacrisert (hydroxypropyl cellulose ophthalmic insert) is a preservative-free, once-daily*, sustained release prescription insert indicated for moderate to severe dry eye, that helps to retain moisture, stabilize the tear film, and lubricate the eye.

"This is the first major study of Lacrisert to be undertaken in more than two decades," stated Michael G. Wells, Chief Executive Officer of Aton Pharma. "Our commitment to expanding product availability and increasing physician awareness and knowledge of Lacrisert includes gathering of key efficacy data such as through this study."

The multicenter, 2-visit, open label, 4-week study was conducted to determine both physician and patient acceptability and ease of use of Lacrisert in adult patients with a history of dry eye syndrome. It was hypothesized that patients would experience improvements in their overall quality of life as well as in measures of dry eye signs and symptoms. A patient registry study is designed to examine a wide range of correlations and show predictive relationships, providing a rich resource of data to mine over time.

Association for Research in Vision and Ophthalmology (ARVO)

Bruce H. Koffler, M.D., will present data from the study in a poster at ARVO, "Lacrisert(R) (hydroxypropyl cellulose ophthalmic insert) Significantly Improves Symptoms of Dry Eye Synd
'/>"/>

SOURCE Aton Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. PSA Screening Cuts Deaths by 20%, Says Worlds Largest Prostate Cancer Study
2. Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study
3. Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer
4. Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
5. CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study
6. NicOx Announces Favorable Blood Pressure Data for Naproxcinod in a Large ABPM Study
7. Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
8. Video: Large, Multi-Center Trial Demonstrates Comparable Accuracy for Virtual Colonoscopy and Standard Colonoscopy
9. Velos Set to Clear 50 Percent Market Penetration of Large U.S. Clinical Research Sites by Year End
10. Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate
11. GlaxoSmithKline Collaborates with National Cancer Institute to Make Large Body of Cancer Cell Genomic Data Available to All Cancer Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... -- RXi Pharmaceuticals Corporation (NASDAQ: RXII ), a biotechnology ... in the areas of dermatology and ophthalmology today announced ... quarter ended June 30, 2015 on Wednesday, August 12, ... A live audio webcast will begin ... under the "Investors" section of the Company,s website, ...
(Date:7/29/2015)... , NEW YORK ... 29, 2015  CMC Biologics, a global leader ... River Vision Development Corporation (River Vision), a private ... have entered into an agreement for the process ... a recombinant monoclonal antibody targeting insulin-like growth factor ...
(Date:7/28/2015)... SAN FRANCISCO , July 28, 2015 ... & Johnson, has introduced a new platform of embolic ... an enhanced detachment system designed to improve microcatheter stability ... . The announcement was made here at the Society ... The family of framing, filling and finishing ...
Breaking Medicine Technology:RXi Pharmaceuticals to Webcast Second Quarter 2015 Financial Results on Wednesday, August 12, 2015 2RXi Pharmaceuticals to Webcast Second Quarter 2015 Financial Results on Wednesday, August 12, 2015 3CMC Biologics and River Vision Development Corporation Announce Manufacturing Agreement for RV001, a Monoclonal Antibody to Treat Grave's Orbitopathy 2CMC Biologics and River Vision Development Corporation Announce Manufacturing Agreement for RV001, a Monoclonal Antibody to Treat Grave's Orbitopathy 3Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 2Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 3Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 4
... Calif., April 26, 2011 BioMarin Pharmaceutical Inc. (Nasdaq: ... Officer of BioMarin, will present a company update at the ... 2011 at 3:30 p.m. ET.   Interested parties ... via the investor section of the BioMarin website, www.BMRN.com ...
... April 26, 2011 AAIPharma Services Corp., a ... services, announced today that it has appointed Paul ... Maffuid will have responsibility for the company,s Drug ... http://photos.prnewswire.com/prnh/20110330/CG74146LOGO ) Dr. Maffuid comes to ...
Cached Medicine Technology:BioMarin to Present at the Deutsche Bank Healthcare Conference 2AAIPharma Services Appoints Maffuid as EVP Operations 2
(Date:7/29/2015)... ... , ... Attorneys representing American families in national talcum powder lawsuits announce the ... a page dedicated to news related to pending talcum powder lawsuits, as well as ... News page was launched with eight initial articles. , “We decided to add ...
(Date:7/29/2015)... ... ... Woodlands and Spring Fit Body Boot Camps have implemented an engaging an interactive way ... system will track each time a client uses social media to Check In at ... will donate 20 cents to a selected charity. , Fit Body Boot Camp is ...
(Date:7/29/2015)... ... July 29, 2015 , ... One of the ... study on the potentially lifesaving impact of removing aluminum from Alzheimer’s disease patients, ... research proposal is based on a successful pilot study published in The Journal ...
(Date:7/29/2015)... ... 29, 2015 , ... ITW Dynatec, along with Zip-Pak and ... is responsible for driving growth and innovation across ITW Dynatec’s worldwide customer base ... an effective leader within the ITW community speaks for itself. We are delighted ...
(Date:7/28/2015)... ... July 29, 2015 , ... City Sports, a specialty sports retailer and ... executive Marty Hanaka as CEO. , Hanaka, who has served on the Board of ... partner at the Highland Consumer Fund has had previous tenures as Chairman and CEO ...
Breaking Medicine News(10 mins):Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 2Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 3Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 2Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 3Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 3Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 2Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 3Health News:City Sports Names Marty Hanaka CEO 2
... patient health, study found , MONDAY, March ... cholesterol, joint physician-pharmacist care to help them manage ... a new study finds. , Canadian researchers looked ... cholesterol-lowering medications and pharmacists provided counseling, requested laboratory ...
... The Emergency Care ... customized training resources based on their new Wilderness First Aid Curriculum and Doctrine Guidelines. ... Sudbury, MA (Vocus) March 8, ... with the Boy Scouts of America (BSA) to provide training resources based on their new ...
... ... been named a Quality Respiratory Care Provider by the American Association for Respiratory Care ... making sure residents cared for by homecare organizations have access to respiratory care services ... ...
... , ... ... , ... ...
... Breast cancer patients with early stage disease that has spread ... after mastectomy, because of the low present-day risk of recurrence ... one day change the course of treatment for thousands of ... of Texas M. D. Anderson Cancer. The research, presented ...
... identified a new reservoir for hidden HIV-infected cells that can serve ... March 7 in Nature Medicine , indicate a new target ... someday no longer rely on AIDS drugs for a lifetime. ... bay. However once the drug therapy is stopped, the virus comes ...
Cached Medicine News:Health News:Emergency Care and Safety Institute Announces New Alliance with Boy Scouts of America 2Health News:Pediatric Home Service (PHS) Named Quality Respiratory Care Provider 2Health News:Pediatric Home Service (PHS) Named Quality Respiratory Care Provider 3Health News:Special Session Highlights Late-Breaking Abstracts 2Health News:Special Session Highlights Late-Breaking Abstracts 3Health News:Special Session Highlights Late-Breaking Abstracts 4Health News:Special Session Highlights Late-Breaking Abstracts 5Health News:Most early stage breast cancer patients may not need radiation after mastectomy 2Health News:Most early stage breast cancer patients may not need radiation after mastectomy 3Health News:University of Michigan scientists discover bone marrow can harbor HIV-infected cells 2
Colour video monitors....
Camera and light source in one compact "Plug-and-Play" device....
... system of choice for customers performing routine ... throughput laboratories in more than 50 countries ... Behring is pleased to announce the placement ... ,The customer centered development process of the ...
... The original ultrasonic ... technology, having an 11-year ... a Large array of ... and femoral applications, cemented ...
Medicine Products: